Obiettivo The effects of glycosylation of proteins are gaining more and more importance, e.g. requirements. Numerous production techniques of recombinant proteins as drugs are developed at the moment. The quality for the pharmaceutical effect of those drugs is often dependent on the glycosylation status. Therefore a constantglycosylation is most crucial and needs to be monitored. Healthcare Technologies has developed a system and reliable method of glycosylation fingerprinting. Phytowelt is working on the production of recombinant proteins in plants and normal profiling by coda micro arrays. To access the utility of this production system both companies aim to evaluate the compatibility of their diagnostic systems to develop a safe and cost efficient production method combined with a method to monitor product quality and reliability in a cost efficient way. Campo scientifico medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsnatural sciencesbiological sciencesbiochemistrybiomoleculesproteins Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-3. - Key action The "Cell factory" Invito a presentare proposte Data not available Meccanismo di finanziamento EAW - Exploratory awards Coordinatore PHYTOWELT GMBH Contributo UE Nessun dato Indirizzo Kölsumer Weg 33 41334 NETTETAL Germania Mostra sulla mappa Costo totale Nessun dato Partecipanti (1) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto HEALTHCARE TECHNOLOGIES LTD Israele Contributo UE Nessun dato Indirizzo 3, habosem St., Kiryat Minrav, 77601 ASHDOD Mostra sulla mappa Costo totale Nessun dato